Arcadia Biosciences Inc
RKDA4.242USD
+0.032+0.76%
Market hours （ET）Quotes delayed by 15 min
5.80MMarket Cap
LossP/E TTM
More Details of Arcadia Biosciences Inc Company
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola). Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (Non-GMO) project verified and only contains 60 calories per serving. It offers Zola in different varieties, such as Original, Slightly Sweetened; Original with Pulp, Slightly Sweetened; Espresso, Slightly Sweetened; Pineapple; Lime; and others. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls.
Company Info
Ticker SymbolRKDA
Company nameArcadia Biosciences Inc
IPO dateMay 15, 2015
CEOMr. Thomas J. Schaefer
Number of employees9
Security typeOrdinary Share
Fiscal year-endMay 15
Address202 Cousteau Place
CityDAVIS
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code95618
Phone15307567077
Websitehttps://arcadiabio.com/
Ticker SymbolRKDA
IPO dateMay 15, 2015
CEOMr. Thomas J. Schaefer
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Mark Kawakami
Mr. Mark Kawakami
Chief Financial Officer
Chief Financial Officer
2.68K
--
Mr. Thomas J. Schaefer
Mr. Thomas J. Schaefer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Deborah (Debbie) Carosella
Ms. Deborah (Debbie) Carosella
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Ms. Amy J. Yoder
Ms. Amy J. Yoder
Independent Director
Independent Director
--
--
Mr. Kevin J. Comcowich
Mr. Kevin J. Comcowich
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Mark Kawakami
Mr. Mark Kawakami
Chief Financial Officer
Chief Financial Officer
2.68K
--
Mr. Thomas J. Schaefer
Mr. Thomas J. Schaefer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Deborah (Debbie) Carosella
Ms. Deborah (Debbie) Carosella
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
4.90M
97.19%
Canada
109.00K
2.16%
Argentina
26.00K
0.52%
India
7.00K
0.14%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Mariner Wealth Advisors
2.01%
The Vanguard Group, Inc.
1.03%
Geode Capital Management, L.L.C.
0.94%
State Street Global Advisors (US)
0.89%
UBS Financial Services, Inc.
0.62%
Other
94.51%
Shareholders
Shareholders
Proportion
Mariner Wealth Advisors
2.01%
The Vanguard Group, Inc.
1.03%
Geode Capital Management, L.L.C.
0.94%
State Street Global Advisors (US)
0.89%
UBS Financial Services, Inc.
0.62%
Other
94.51%
Shareholder Types
Shareholders
Proportion
Investment Advisor
3.68%
Investment Advisor/Hedge Fund
1.84%
Individual Investor
0.82%
Research Firm
0.06%
Hedge Fund
0.03%
Other
93.57%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
35
87.93K
6.43%
-233.63K
2025Q1
38
87.93K
6.43%
-244.41K
2024Q4
49
156.69K
11.48%
-110.76K
2024Q3
49
100.21K
9.85%
-202.17K
2024Q2
47
71.82K
7.77%
-229.97K
2024Q1
51
258.53K
25.32%
-38.12K
2023Q4
56
321.69K
30.80%
+98.94K
2023Q3
62
165.26K
19.23%
-273.71K
2023Q2
66
255.84K
27.41%
-81.95K
2023Q1
69
274.06K
33.25%
+123.06K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Mariner Wealth Advisors
27.48K
2.01%
+2.48K
+9.92%
Mar 31, 2025
The Vanguard Group, Inc.
14.04K
1.03%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
12.79K
0.94%
+498.00
+4.05%
Mar 31, 2025
State Street Global Advisors (US)
12.15K
0.89%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
8.53K
0.62%
-5.38K
-38.71%
Mar 31, 2025
Jacot (Stanley Jr)
5.00K
0.37%
--
--
Mar 31, 2025
Schaefer (Thomas J.)
2.82K
0.21%
--
--
Mar 31, 2025
Kawakami (Mark)
2.68K
0.2%
--
--
Mar 31, 2025
Morgan Stanley & Co. LLC
606.00
0.04%
--
--
Mar 31, 2025
Comcowich (Kevin J.)
500.00
0.04%
--
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
Date
Type
Ratio
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
Feb 28, 2023
Merger
40<1
